Jia Jie Biomedical Co., Ltd. (4109.TWO)
Taipei Exchange · TWD · Consumer Defensive · Packaged Foods
NT$10.85 (-0.91%) as of
Key statistics
- Market cap
- 1.29B
- P/E (TTM)
- 361.67
- EPS (TTM)
- 0.03
- Dividend yield
- 1.83%
- 52-week range
- 10.35 – 16.90
- Beta
- -0.05
- Revenue (TTM)
- 514.65M
- Profit margin
- 0.60%
- Volume
- 124.08k
About Jia Jie Biomedical Co., Ltd.
Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules; and import and export, distribution, bidding, quotation of the products. It also involved in the wholesale of nonalcoholic beverages, candy, baked food, supplementary food, groceries, daily commodities, and cosmetics; production of water purification equipment and related parts; life and property insurance brokerage business; development and production of aquatic product technology; and development of biological products. The company was formerly known as Murad Chia Jei Biotechnology Co., Ltd. and changed its name to Jia Jie Biomedical Co., Ltd. in June 2019. Jia Jie Biomedical Co., Ltd. was founded in 1995 and is based in Kaohsiung, Taiwan.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Headquarters
- Kaohsiung, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.